Acurx Pharmaceuticals, Inc.
NASDAQ:ACXP
0.7199 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||||
Net Income
| -2.822 | -4.122 | -4.378 | -5.115 | -3.115 | -3.445 | -2.903 | -3.261 | -3.542 | -2.621 | -2.67 | -2.627 | -4.642 | -4.004 | -1.474 | -1.093 | -1.315 | -0.913 | -1.279 |
Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0.318 | 1.017 | 1.2 | 1.227 | 0.833 | 0.806 | 0.899 | 0.697 | 0.824 | 0.717 | 0.949 | 0.76 | 3.398 | 2.257 | 0.327 | 0.286 | 0.307 | 0.328 | 0.348 |
Change In Working Capital
| -0.126 | -0.032 | 0.115 | -0.31 | 0.188 | 1.062 | 0.071 | 0.952 | 0.537 | -0.087 | -0.155 | 0.367 | -1.392 | 1.483 | -0.317 | -0.152 | 0.249 | -0.148 | -0.75 |
Accounts Receivables
| 0 | 0 | 0.129 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Accounts Payables
| 0 | 0 | 67.804 | 968.456 | 0 | 0 | 12.297 | 1.218 | 0 | -0.37 | -210.881 | 0.388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -0.126 | -0.032 | -0.014 | -0.31 | 0.188 | 1.062 | -12.297 | -0.265 | 0.537 | 0.283 | 210.726 | -0.021 | -0.186 | 1.483 | -0.305 | -0.041 | 0.005 | -0.001 | 0.035 |
Other Non Cash Items
| 0.44 | 0.256 | 1.071 | 0.394 | 0.833 | 0.806 | 0.899 | 0.812 | 0.824 | 0.717 | 0.949 | 0.76 | 0.046 | -0.067 | 0.917 | -0.112 | 0.376 | 0.014 | 0.782 |
Operating Cash Flow
| -2.19 | -2.88 | -3.063 | -4.198 | -2.094 | -1.577 | -1.933 | -1.496 | -2.18 | -1.991 | -1.876 | -1.5 | -2.637 | -0.33 | -0.547 | -0.96 | -0.759 | -0.734 | -0.899 |
Investing Activities: | |||||||||||||||||||
Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing Activities: | |||||||||||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.067 | 0 |
Common Stock Issued
| 1.592 | 0.32 | 4.299 | 2.401 | 0 | 3.544 | 0 | 3.695 | 3.695 | 0 | 0 | -14.797 | 0 | 14.797 | 0 | 0.729 | 2.191 | 1.058 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 6,414.988 | 0 | 0.21 | 4.62 | 0 | 0 | 0 | -3.695 | 3.695 | 0 | 0 | 14,782.335 | 0 | 0 | 0 | 0 | 0 | 1.058 | 0 |
Financing Cash Flow
| 6,416.579 | 0.32 | 4.51 | 4.62 | 0 | 3.544 | 0 | -0 | 3.695 | 0 | 0 | 14,782.335 | 0 | 14.797 | 0 | 0.729 | 2.191 | 1.124 | 0 |
Other Information: | |||||||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -0.598 | -2.56 | 1.447 | 0.422 | -2.094 | -8.755 | -1.933 | -1.496 | 1.515 | -1.991 | -1.876 | -1.5 | -2.637 | 14.467 | -0.547 | -0.231 | 1.432 | 0.39 | -0.899 |
Cash At End Of Period
| 5.763 | 6.361 | 8.921 | 7.474 | 7.052 | -1.577 | 7.179 | 9.112 | 10.607 | 9.092 | 11.083 | 12.959 | 14.459 | 17.096 | 2.628 | 3.175 | 3.407 | 1.974 | 1.584 |